2000
T‐gamma gene rearrangement and CMV mononucleosis
Mathew P, Hudnall S, Elghetany M, Payne D. T‐gamma gene rearrangement and CMV mononucleosis. American Journal Of Hematology 2000, 66: 64-66. PMID: 11426498, DOI: 10.1002/1096-8652(200101)66:1<64::aid-ajh1013>3.0.co;2-v.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, ViralBlood CellsBone Marrow CellsClone CellsCytomegalovirusCytomegalovirus InfectionsDiagnosis, DifferentialFemaleGene Rearrangement, gamma-Chain T-Cell Antigen ReceptorHumansImmunoglobulin MImmunophenotypingInfectious MononucleosisLymphoproliferative DisordersMiddle AgedT-Lymphocyte SubsetsViremiaConceptsT gamma gene rearrangementCMV infectionLymphoproliferative diseaseAcute CMV infectionGene rearrangementsAtypical lymphocytosisCMV mononucleosisCMV viremiaNight sweatsIgM serologyClinical featuresLymphoid aggregatesBlood countPeripheral bloodHemolytic anemiaImmune responseBone marrowWeight lossCytomegalovirusInfectionDiseaseMononucleosisViremiaSplenomegalyLymphocytosis
1996
MASSIVE PSEUDOLYMPHOMATOUS PERICARDIAL EFFUSION IN THE POSTTRANSPLANT SETTING MIMICKING POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE
Hudnall1 2, Kathleen M, A. G, Yvonne B. MASSIVE PSEUDOLYMPHOMATOUS PERICARDIAL EFFUSION IN THE POSTTRANSPLANT SETTING MIMICKING POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE. Transplantation 1996, 61: 1776-1778. PMID: 8685960, DOI: 10.1097/00007890-199606270-00020.Peer-Reviewed Original ResearchMeSH KeywordsBase SequenceB-LymphocytesChild, PreschoolDiagnosis, DifferentialHeart TransplantationHumansLymphoproliferative DisordersMaleMolecular Sequence DataPericardial EffusionConceptsPericardial effusionLymphocytic effusionsLymphoproliferative disordersB-cell lymphoproliferative disordersBenign pericardial effusionCardiac transplant teamPosttransplant lymphoproliferative diseaseCardiac transplant recipientsCell lymphoproliferative disordersImmunosuppressant withdrawalTransplant recipientsTransplant settingLymphoproliferative diseaseTransplant teamOpposite therapyImmunophenotypic dataTransplant processUnusual caseEffusionDetailed histologicDiagnostic distinctionEBVDisorders
1994
Multiple myeloma after cardiac transplantation: An unusual form of posttransplant lymphoproliferative disorder
Chucrallah A, Crow M, Rice L, Rajagopalan S, Hudnall S. Multiple myeloma after cardiac transplantation: An unusual form of posttransplant lymphoproliferative disorder. Human Pathology 1994, 25: 541-545. PMID: 8200651, DOI: 10.1016/0046-8177(94)90129-5.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, ViralBase SequenceDNA-Binding ProteinsEpstein-Barr Virus Nuclear AntigensGene RearrangementGenes, ImmunoglobulinHeart TransplantationHerpesvirus 4, HumanHumansIn Situ HybridizationLymphoproliferative DisordersMaleMiddle AgedMolecular Sequence DataMultiple MyelomaPolymerase Chain ReactionRNA, ViralConceptsPosttransplant lymphoproliferative disorderPolymerase chain reactionCardiac transplantationLymphoproliferative disordersMonoclonal immunoglobulin heavy chain gene rearrangementEBV-negative casesPast EBV infectionCardiac transplant recipientsImmature plasma cellsImmunoglobulin heavy chain gene rearrangementHeavy chain gene rearrangementChain gene rearrangementCyclosporin withdrawalEBV infectionTransplant recipientsEBER-1Monomorphous populationMultiple myelomaEBV genomePlasma cellsSkull lesionsMyelomaSerum analysisGene rearrangementsChain reaction
1991
Cyclosporin A renders target cells resistant to immune cytolysis
Hudnall S. Cyclosporin A renders target cells resistant to immune cytolysis. European Journal Of Immunology 1991, 21: 221-226. PMID: 1846819, DOI: 10.1002/eji.1830210133.Peer-Reviewed Original ResearchConceptsCsA dose reductionB-cell hyperplasiaB lymphocytesDose reductionCell growth inhibitionNatural killerCell hyperplasiaEarly post-transplant lymphoproliferative disordersHuman organ transplant recipientsPost-transplant lymphoproliferative disorderT cell-dependent responsesAntibody-dependent responsesPost-transplant settingOrgan transplant recipientsTarget cellsEpstein-Barr virusCell-dependent responsesHuman target cellsComplement-mediated cytolysisGrowth inhibitionTransplant recipientsDisease regressionImmune controlNK cellsLymphoproliferative disorders